Approaches to inactivate FRA1 and/or pathways through which its pro-malignant actions are mediated may hence provide an approach to modulate EMT-MET balances and impede the spread of CRC and other cancers in which the RAS-ERK pathway is hyperactive. This evidence concerns the gene FOSL1 and cancer.